Synthesis and biological evaluation of a novel anticancer agent CBISC that induces DNA damage response and diminishes levels of mutant-p53

Conor T. Ronayne; Sravan K. Jonnalagadda; Shirisha Jonnalagadda; Grady L. Nelson; Lucas N. Solano; Hithardha Palle; Chinnadurai Mani; Jon Rumbley; Jon Holy; Venkatram R. Mereddy

doi:10.1016/j.bbrc.2021.05.062

Synthesis and biological evaluation of a novel anticancer agent CBISC that induces DNA damage response and diminishes levels of mutant-p53

Conor T. Ronayne, Sravan K. Jonnalagadda, Shirisha Jonnalagadda, Grady L. Nelson, Lucas N. Solano, Hithardha Palle, Chinnadurai Mani, Jon Rumbley, Jon Holy, Venkatram R. Mereddy

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

A novel nitrogen mustard CBISC has been synthesized and evaluated as an anticancer agent. CBISC has been shown to exhibit enhanced cell proliferation inhibition properties against mutant p53 cell lines colorectal cancer WiDr, pancreatic cancer (MIAPaCa-2 and PANC-1), and triple negative breast cancer (MDA-MB-231 and MDA-MB-468). In vitro mechanism of action studies revealed perturbations in the p53 pathway and increased cell death as evidenced by western blotting, immunofluorescent microscopy and MTT assay. Further, in vivo studies revealed that CBISC is well tolerated in healthy mice and exhibited significant in vivo tumor growth inhibition properties in WiDr and MIAPaCa-2 xenograft models. These studies illustrate the potential utility of CBISC as an anticancer agent.

Original language	English (US)
Pages (from-to)	127-132
Number of pages	6
Journal	Biochemical and Biophysical Research Communications
Volume	562
DOIs	https://doi.org/10.1016/j.bbrc.2021.05.062
State	Published - Jul 12 2021

Bibliographical note

Funding Information:
This work was supported by University of Minnesota Duluth ; Whiteside Clinical Research Institute, Minnesota , and Randy Shaver Cancer Research and Community Fund, Minnesota .

Publisher Copyright:
© 2021

Keywords

Alkylating agent
Apoptosis
DNA-damage
MIAPaCa-2
Mutant p53
WiDr

PubMed: MeSH publication types

Journal Article
Research Support, Non-U.S. Gov't

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1016/j.bbrc.2021.05.062

OpenUrl availability

Full text

Cite this

Ronayne, C. T., Jonnalagadda, S. K., Jonnalagadda, S., Nelson, G. L., Solano, L. N., Palle, H., Mani, C., Rumbley, J., Holy, J., & Mereddy, V. R. (2021). Synthesis and biological evaluation of a novel anticancer agent CBISC that induces DNA damage response and diminishes levels of mutant-p53. Biochemical and Biophysical Research Communications, 562, 127-132. https://doi.org/10.1016/j.bbrc.2021.05.062

Synthesis and biological evaluation of a novel anticancer agent CBISC that induces DNA damage response and diminishes levels of mutant-p53. / Ronayne, Conor T.; Jonnalagadda, Sravan K.; Jonnalagadda, Shirisha et al.
In: Biochemical and Biophysical Research Communications, Vol. 562, 12.07.2021, p. 127-132.

Research output: Contribution to journal › Article › peer-review

Ronayne, CT, Jonnalagadda, SK, Jonnalagadda, S, Nelson, GL, Solano, LN, Palle, H, Mani, C, Rumbley, J , Holy, J & Mereddy, VR 2021, 'Synthesis and biological evaluation of a novel anticancer agent CBISC that induces DNA damage response and diminishes levels of mutant-p53', Biochemical and Biophysical Research Communications, vol. 562, pp. 127-132. https://doi.org/10.1016/j.bbrc.2021.05.062

@article{f2102052c53349e9828e28f83e3a9813,

title = "Synthesis and biological evaluation of a novel anticancer agent CBISC that induces DNA damage response and diminishes levels of mutant-p53",

abstract = "A novel nitrogen mustard CBISC has been synthesized and evaluated as an anticancer agent. CBISC has been shown to exhibit enhanced cell proliferation inhibition properties against mutant p53 cell lines colorectal cancer WiDr, pancreatic cancer (MIAPaCa-2 and PANC-1), and triple negative breast cancer (MDA-MB-231 and MDA-MB-468). In vitro mechanism of action studies revealed perturbations in the p53 pathway and increased cell death as evidenced by western blotting, immunofluorescent microscopy and MTT assay. Further, in vivo studies revealed that CBISC is well tolerated in healthy mice and exhibited significant in vivo tumor growth inhibition properties in WiDr and MIAPaCa-2 xenograft models. These studies illustrate the potential utility of CBISC as an anticancer agent.",

keywords = "Alkylating agent, Apoptosis, DNA-damage, MIAPaCa-2, Mutant p53, WiDr",

author = "Ronayne, {Conor T.} and Jonnalagadda, {Sravan K.} and Shirisha Jonnalagadda and Nelson, {Grady L.} and Solano, {Lucas N.} and Hithardha Palle and Chinnadurai Mani and Jon Rumbley and Jon Holy and Mereddy, {Venkatram R.}",

note = "Funding Information: This work was supported by University of Minnesota Duluth ; Whiteside Clinical Research Institute, Minnesota , and Randy Shaver Cancer Research and Community Fund, Minnesota . Publisher Copyright: {\textcopyright} 2021",

year = "2021",

month = jul,

day = "12",

doi = "10.1016/j.bbrc.2021.05.062",

language = "English (US)",

volume = "562",

pages = "127--132",

journal = "Biochemical and Biophysical Research Communications",

issn = "0006-291X",

publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Synthesis and biological evaluation of a novel anticancer agent CBISC that induces DNA damage response and diminishes levels of mutant-p53

AU - Ronayne, Conor T.

AU - Jonnalagadda, Sravan K.

AU - Jonnalagadda, Shirisha

AU - Nelson, Grady L.

AU - Solano, Lucas N.

AU - Palle, Hithardha

AU - Mani, Chinnadurai

AU - Rumbley, Jon

AU - Holy, Jon

AU - Mereddy, Venkatram R.

N1 - Funding Information: This work was supported by University of Minnesota Duluth ; Whiteside Clinical Research Institute, Minnesota , and Randy Shaver Cancer Research and Community Fund, Minnesota . Publisher Copyright: © 2021

PY - 2021/7/12

Y1 - 2021/7/12

N2 - A novel nitrogen mustard CBISC has been synthesized and evaluated as an anticancer agent. CBISC has been shown to exhibit enhanced cell proliferation inhibition properties against mutant p53 cell lines colorectal cancer WiDr, pancreatic cancer (MIAPaCa-2 and PANC-1), and triple negative breast cancer (MDA-MB-231 and MDA-MB-468). In vitro mechanism of action studies revealed perturbations in the p53 pathway and increased cell death as evidenced by western blotting, immunofluorescent microscopy and MTT assay. Further, in vivo studies revealed that CBISC is well tolerated in healthy mice and exhibited significant in vivo tumor growth inhibition properties in WiDr and MIAPaCa-2 xenograft models. These studies illustrate the potential utility of CBISC as an anticancer agent.

AB - A novel nitrogen mustard CBISC has been synthesized and evaluated as an anticancer agent. CBISC has been shown to exhibit enhanced cell proliferation inhibition properties against mutant p53 cell lines colorectal cancer WiDr, pancreatic cancer (MIAPaCa-2 and PANC-1), and triple negative breast cancer (MDA-MB-231 and MDA-MB-468). In vitro mechanism of action studies revealed perturbations in the p53 pathway and increased cell death as evidenced by western blotting, immunofluorescent microscopy and MTT assay. Further, in vivo studies revealed that CBISC is well tolerated in healthy mice and exhibited significant in vivo tumor growth inhibition properties in WiDr and MIAPaCa-2 xenograft models. These studies illustrate the potential utility of CBISC as an anticancer agent.

KW - Alkylating agent

KW - Apoptosis

KW - DNA-damage

KW - MIAPaCa-2

KW - Mutant p53

KW - WiDr

UR - http://www.scopus.com/inward/record.url?scp=85106658807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85106658807&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2021.05.062

DO - 10.1016/j.bbrc.2021.05.062

M3 - Article

C2 - 34051576

AN - SCOPUS:85106658807

SN - 0006-291X

VL - 562

SP - 127

EP - 132

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

ER -

Synthesis and biological evaluation of a novel anticancer agent CBISC that induces DNA damage response and diminishes levels of mutant-p53

Abstract

Bibliographical note

Keywords

PubMed: MeSH publication types

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this